Omics! Omics!

In the closing talk of the pre-London Calling workshop, Hans Jansen had closed his presentation with a question whether at some future date ...

Okay, I'm desperately behind on writing up the external science from London Calling.  Not helpful that I claimed I would not only do so,...

Jonathan Jacobs posted his annual reminder that the Sequencing, Finishing and Analysis in the Future Meeting (SFAF) will be this week.  Alas...

London Calling 2017 came to a close last Friday.  Any excuses of jet lag or nights running up ONT's bar tab won't hold up much longe...

I attended on Wednesday the London Calling pre-conference workshop, an add-on for those wishing for help getting started with MinION sequenc...

Oxford Nanopore's London Calling confab runs Thursday and Friday, with a training workshop on Wednesday.  I'll be there -- who can r...

Oxford Nanopore has launched lawsuits in the UK and Germany against Pacific Biosciences, alleging infringement of a European patent license...

A pretty common question over on Quora is something along the lines of "how do I learn bioinformatics".  Great question!  Tonight ...

In my recent piece on long read assembly , I laid out part of the case against the N50 statistic.  Historically, the issues with the statist...

A TV movie produced by and starring American culture mogul Oprah Winfrey is about to hit screens which dramatizes Rebecca Skloot's The I...

A restaurant I frequented during my grad school days had a map on the wall showing Boston area transit routes from roughly the 1940s.  Remar...

Adaptive immunity is an endlessly fascinating topic which I have not explored very deeply, which is particularly unfortunate given the many ...

Advances in optical mapping, linked reads, PacBio and nanopore sequencing are enabling generating highly contiguous large genome sequences ...

A new paper on using Hi-C sequencing appeared in Science recently, demonstrating the generation of chromosome-length scaffolds for human as ...

I've been contemplating this post for a while, but it can be seen as another angle on my recent post on the challenges of drug discovery...

My correspondent @datarade shot a tweet my way on his quest to understand drug discovery. He does this despite the fact I've promised po...

Pacific Biosciences has made new thrusts in their ongoing intellectual property action against Oxford Nanopore, adding two recently issued ...

The advent of so-called next generation sequencers, particularly those from Illumina, have brought the price of sequence data down dramatica...

Clive Brown gave a webcast today with updates on a number of Oxford Nanopore topics, but clearly the flagship announcement was a new instrum...

Last week I posted a piece  on some amazing new nanopore data, only to be red-faced to discover the next morning that I had misread the a...